Blue Ledge Capital
Venture capitalSeed–Growth · 1 people tracked
Investment thesis
Blue Ledge Capital invests in businesses building the future, particularly focusing on advanced technology and deep science-based opportunities where others see confusion. The firm partners with institutional backing to enable a sustainable model without asset accumulation pressures, allowing for patient capital deployment alongside rigorous diligence and long-term portfolio support.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directories
What they invest in
from 4 of 8 portfolio companiesAI & Machine Learning ×1Biotech ×1Climate Tech ×1Deep Tech ×1Digital Health ×1FoodTech ×1Hardware ×1Healthtech ×1
HQs:United States×3
Investments · 8 tracked
founders shown can be your intro pathThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support.
HealthtechImpact & Social Good
Co-investorsBrightEdgeFred Hutchinson Cancer Research Center
Grolltex is a U.S.-based manufacturer of CVD (chemical vapor deposition) monolayer graphene and hexagonal boron nitride (hBN) single-atom films.
Deep TechHardwareNew Materials
Co-investorsVertical Venture Partners
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)
BoardDavid Bowman(Director)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Joyance PartnersLever VC+6 more
Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation.
AI & Machine LearningBiotechDigital HealthMedical DevicesRichmond, US
Mario Danek(Founder)Brian Quigley(Executive Officer, Director)
BoardSean Fahey(Director)Brian Riano(Director)Gregg Smith(Director)in
Co-investorsEvolution VC PartnersVice Ventures
Developer of an inhalation device and liquid formulation to deliver inhalable nicotine without harmful constituents, pursuing FDA 505(b)(2) authorization for the first inhalable Nicotine Replacement Therapy; BlueLedge led its bridge rounds ahead of its 2020/2021 Series A.
Portfolio news
latest coverage across their companiesMission Barns · sfexaminer.com · Sep 10, 2025
Frequently asked questions
- How many investments has Blue Ledge Capital made?
- Blue Ledge Capital has 7 tracked investments.
- What stage does Blue Ledge Capital invest at?
- Blue Ledge Capital invests at the Seed, Series A, Growth stages.
- What sectors does Blue Ledge Capital focus on?
- Blue Ledge Capital focuses on Biotech, Deep Tech, FoodTech, Medical Devices, New Materials.
- Does Blue Ledge Capital lead rounds?
- Yes, Blue Ledge Capital leads investment rounds.
- Who does Blue Ledge Capital co-invest with?
- Blue Ledge Capital most often shares deals with Air Street Capital, Better Ventures Central Llc, Lever VC, among 10 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Serra Ventures is an early-stage technology venture capital firm that has funded over 100 startups across the United States, with a notable focus on agtech and food tech alongside other technology sectors.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.